Figure 2.
Overexpression of Bcl-xLprevents BCR- or arachidonic acid–mediated apoptosis, but not growth arrest, in WEHI-231 immature B cells. Growth arrest was assessed by measurement of anti-Ig- or arachidonic acid–mediated suppression of DNA synthesis by WEHI-231 B cells. (A) WEHI-231-Neo (□) or -Bcl-xL (▪) B cells were treated for 48 hours with 0 to 10 μg/mL anti-IgM or anti-IgM plus anti-CD40 (aIg + aCD40, both at 10 μg/mL), and levels of [3H]-thymidine incorporation into DNA were measured. (B) WEHI-231-Neo (□) or -Bcl-xL (▪) B cells were treated for 48 hours with 0 to 100 μM arachidonic acid or 10 μg/mL anti-IgM, and levels of [3H]-thymidine incorporation into DNA were measured. Data are expressed as means ± SD (n = 3) from single experiments representative of at least 2 other independent experiments. (C) WEHI-231-Neo (□) or -Bcl-xL (▪) B cells were treated for 48 hours with 100 μM arachidonic acid (AA), 10 μg/mL of anti-IgM (aIg), 10 μg/mL anti-CD40 (aCD40), or anti-IgM plus anti-CD40 (aIg/CD40, both at 10 μg/mL), and percentages of apoptotic cells were determined. Data are expressed as means ± SEM and are pooled from up to 13 individual experiments. (D) WEHI-231-Neo (open symbols) or WEHI-231Bcl-xL (filled symbols) B cells were treated for up to 72 hours with medium (squares), 100 μM arachidonic acid (circles), or 10 μg/mL anti-IgM (diamonds) before determining the resulting levels of apoptosis. Apoptosis was measured by propidium iodide (PI) staining of subdiploid DNA content as described in “Materials and methods.”